Novozymes delivers solid Q1 results with 3% organic sales growth and strong earnings
Novozymes delivered 3% organic sales growth in the first quarter of the 2021 financial year and an EBIT margin of 29.6%.
The company maintains its full-year financial guidance.
COPENHAGEN, Denmark – April 27, 2021. With 3% organic sales growth in Q1, Novozymes is off to a good start to the year. Despite currency headwinds and negative M&A-related effects, Novozymes delivers an EBIT-margin of 29.6%. ROIC including goodwill was 23.4%.
"I am very pleased with our first quarter results, and I am sincerely impressed by the organization’s ability to rapidly adapt to changing conditions and be there to service our customers. Our sales ended well above our initial expectations and this was mainly due to favorable timing. But we also see some indications of better momentum in the underlying performance, especially in the emerging markets. While we are off to a good start, we maintain our full-year financial guidance due to timing factors, supply-chain volatility, and continued COVID-19 uncertainty,” says Ester Baiget, President & CEO and continues:
“Our growth is supported by innovation, a stronger commercial presence, and a more streamlined organization. Earlier this month, we completed our Executive Leadership Team with Amy Byrick as new EVP of Strategy & Business Transformation and Morten Enggaard Rasmussen as new EVP of People, Sustainability & Brand. Together with our employees, we continue to execute on our strategic priorities and shape the future of Novozymes.”
Regional and business area results
For Q1, organic growth rates by business area were 2% in Household Care, 11% in Food, Beverages & Human Health, -9% in Bioenergy, 16% in Grain & Tech Processing, 0% in Agriculture, Animal Health & Nutrition.
Organic sales in Household Care were driven by continued market penetration in emerging markets and rollout of the Freshness technology in Europe. Household Care also benefitted from customers building stock, especially in emerging markets, and faster market recovery in China. In Food, Beverages & Human Health, organic sales were led by high growth in dairy and protein ingredients and sales was positively affected by customers building stock and a faster recovery, particularly in emerging markets.